Phenytoin Induced Cerebral Atrophy: A Case Report

Authors

  • Celeste Linggi Pharm D. Intern, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India https://orcid.org/0000-0001-9407-8252
  • Anit Mathews Pharm D. Intern, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India https://orcid.org/0000-0002-5383-1102
  • Rasi Mopidevi Pharm D. Intern, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India https://orcid.org/0000-0002-2483-8372
  • Sanat Kumar B. Nyamagoud Assistant Professor, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India
  • Usha D.S. Assistant Professor, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India

Abstract

Phenytoin is the most common drug prescribed in patient diagnosed with seizure. Cerebral atrophy is an observed complication in phenytoin exposed patients. The side effects related to phenytoin administration include sedation, dizziness, swaying, rash and gum hypertrophy. In the following case report a 50-year-old male patient with complaints of poor response to oral commands, slurred speech, limited upper limb movements and neck rigidity, the patient is a known epileptic since 1 year on prescription and is alcoholic. Upon CT scan of brain, the impression was mild diffuse cerebellar atrophy probably due to long term phenytoin use. Hence frequent phenytoin level monitoring in patient prescribed with the same is mandatory.

Keywords: phenytoin, epilepsy, cerebral atrophy

Keywords:

phenytoin, epilepsy, cerebral atrophy

DOI

https://doi.org/10.22270/jddt.v12i5.5640

Author Biographies

Celeste Linggi, Pharm D. Intern, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India

Pharm D. Intern, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India

Anit Mathews, Pharm D. Intern, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India

Pharm D. Intern, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India

Rasi Mopidevi, Pharm D. Intern, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India

Pharm D. Intern, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India

Sanat Kumar B. Nyamagoud, Assistant Professor, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India

Assistant Professor, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India

Usha D.S., Assistant Professor, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India

Assistant Professor, K.L.E. Society’s, College of Pharmacy, Hubballi 580031, India

References

Kodam V, Srinivas DS, Sanda MR, Kanni YS, Venkat KT, Shravan, Phenytoin Induced Cerebellar Atrophy - A Case Report, JBCR, 2016; 3(2) https://jbcr.net.in/volume3-issue2-casereport3.htm

Satheesh G, Varma S, Antony A. Case Report on Phenytoin Induced Cerebellar Syndrome. Indian Journal of Pharmacy Practice. 2018; 11:58-60. DOI:10.5530/ijopp.11.1.11

De Marcos FA, Ghizoni E, Kobayashi E, Li LM, Cendes F. Cerebellar volume and long-term use of phenytoin. Seizure. 2003 Jul; 12(5):312-5. DOI: 10.1016/s1059-1311(02)00267-4 PMID: 12810345.

Cerebral Atrophy (Brain Atrophy): Symptoms, Causes, and Diagnosis (healthgrades.com)

Wikipedia

Published

2022-09-15
Statistics
Abstract Display: 639
PDF Downloads: 692
PDF Downloads: 121

How to Cite

1.
Linggi C, Mathews A, Mopidevi R, Nyamagoud SKB, D.S. U. Phenytoin Induced Cerebral Atrophy: A Case Report. J. Drug Delivery Ther. [Internet]. 2022 Sep. 15 [cited 2026 Jan. 21];12(5):1-2. Available from: https://jddtonline.info/index.php/jddt/article/view/5640

How to Cite

1.
Linggi C, Mathews A, Mopidevi R, Nyamagoud SKB, D.S. U. Phenytoin Induced Cerebral Atrophy: A Case Report. J. Drug Delivery Ther. [Internet]. 2022 Sep. 15 [cited 2026 Jan. 21];12(5):1-2. Available from: https://jddtonline.info/index.php/jddt/article/view/5640